2021
DOI: 10.1136/bmjoq-2020-001204
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating an enhanced quality improvement intervention in maternity units: PReCePT trial protocol

Abstract: The UK’s National Institute for Health and Care Excellence Preterm labour and birth guideline recommends use of magnesium sulfate (MgSO4) in deliveries below 30 weeks’ gestation to prevent cerebral palsy and other neurological problems associated with preterm delivery. Despite national guidance, the uptake of MgSO4 administration in eligible women has been slow. National Health Service England has rolled out the PReCePT (PRevention of Cerebral Palsy in Pre-Term labour) quality improvement (QI) toolkit to incre… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
2

Relationship

3
2

Authors

Journals

citations
Cited by 8 publications
(13 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…From the 150 NPP units, a further 13 units were excluded as these comprised the PReCePT trial ESP group. 13 This left 137 maternity units in the evaluation.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…From the 150 NPP units, a further 13 units were excluded as these comprised the PReCePT trial ESP group. 13 This left 137 maternity units in the evaluation.…”
Section: Resultsmentioning
confidence: 99%
“…The RCT comparing MgSO4 uptake in NPP units versus those receiving enhanced support is reported separately, but results were comparable to those reported here. 13,14 The analyses are also limited to the available data (i.e., to June 2020), it is probable that NPP benefits will persist; therefore, sustainability analyses need to be addressed in future studies.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations